Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Ribosome,0.003997779146918023,3.0895100502512562,17.06032481114942,"['RPS16', 'RPL27A', 'RPS6', 'RPLP0', 'RPL36', 'RPL14', 'RPL23A', 'RPS11', 'MRPL34']",0.5045524563300153,0,0,9
2,Thermogenesis,0.004275868273983181,2.5558136500065247,13.941370747642168,"['COX8A', 'CREB3', 'NDUFB9', 'NDUFAF4', 'RPS6', 'ZNF516', 'NDUFS3', 'NDUFAF3', 'KRAS', 'CYC1', 'COX5A', 'ATP5F1D']",0.5045524563300153,0,0,12
3,Steroid biosynthesis,0.008614881808148001,8.168316831683168,38.834335702325674,"['CYP51A1', 'DHCR24', 'MSMO1']",0.6777040355743095,0,0,3
4,Natural killer cell mediated cytotoxicity,0.012578629544518792,3.324324324324324,14.54643201792448,"['FCGR3A', 'SHC3', 'HLA-B', 'RAC3', 'KRAS', 'ICAM1']",0.7421391431266088,0,0,6
5,Oxidative phosphorylation,0.01854562444256486,2.735,10.905871020410897,"['COX8A', 'NDUFB9', 'NDUFS3', 'CYC1', 'ATP6V0D1', 'COX5A', 'ATP5F1D']",0.8355841201906211,0,0,7
6,African trypanosomiasis,0.021456627892226552,5.566944194419442,21.386650251438695,"['HBA2', 'HBA1', 'ICAM1']",0.8355841201906211,0,0,3
7,Viral carcinogenesis,0.030765091573679706,2.2794486215538847,7.935614583778206,"['CREB3', 'GTF2A2', 'PKM', 'IRF3', 'BAD', 'HLA-B', 'KRAS', 'ATP6V0D1']",0.8355841201906211,0,0,8
8,Coronavirus disease,0.031253395547835246,2.1486356199602663,7.446370157372716,"['RPS16', 'IRF3', 'RPL27A', 'RPLP0', 'RPS6', 'RPL36', 'RPL14', 'RPL23A', 'RPS11']",0.8355841201906211,0,0,9
9,Glycolysis / Gluconeogenesis,0.031865496108964365,3.553565648937318,12.24640981005585,"['LDHA', 'PKM', 'PGAM1', 'GAPDH']",0.8355841201906211,0,0,4
10,Huntington disease,0.037186401999487494,1.85579137717712,6.108916551622067,"['COX8A', 'CREB3', 'NDUFB9', 'PSMC3', 'ATG101', 'DCTN1', 'CLTC', 'NDUFS3', 'CYC1', 'COX5A', 'ATP5F1D', 'SLC25A4']",0.8380390639584117,0,0,12
11,Amyotrophic lateral sclerosis,0.05041104694049292,1.7191310166974065,5.135981174592826,"['COX8A', 'NDUFB9', 'DCTN1', 'BAD', 'COX5A', 'ATP5F1D', 'PINK1', 'PSMC3', 'ATG101', 'NDUFS3', 'SRSF3', 'CYC1', 'NEFH']",0.8380390639584117,0,0,13
12,Neuroactive ligand-receptor interaction,0.05198784791741266,1.8656972750171743,5.516391614814616,"['POMC', 'NPB', 'CHRNB3', 'CHRNA2', 'FSHR', 'APLNR', 'OPRL1', 'GNRH1', 'CCK', 'HCRTR1']",0.8380390639584117,0,0,10
13,Alzheimer disease,0.05244641309368165,1.70793532378651,5.034930710741073,"['COX8A', 'NDUFB9', 'BAD', 'COX5A', 'ATP5F1D', 'HSD17B10', 'PSMC3', 'ATG101', 'NDUFS3', 'KRAS', 'CYC1', 'GAPDH', 'SLC25A4']",0.8380390639584117,0,0,13
14,Diabetic cardiomyopathy,0.05647038261975544,1.999021945106669,5.745266991495483,"['COX8A', 'NDUFB9', 'NDUFS3', 'CYC1', 'COX5A', 'ATP5F1D', 'GAPDH', 'SLC25A4']",0.8380390639584117,0,0,8
15,Malaria,0.0587912519334544,3.599519510774607,10.200182370226099,"['HBA2', 'HBA1', 'ICAM1']",0.8380390639584117,0,0,3
16,Prion disease,0.06393219873265958,1.791382970532267,4.926181627176075,"['COX8A', 'CREB3', 'NDUFB9', 'PSMC3', 'BAD', 'NDUFS3', 'CYC1', 'COX5A', 'ATP5F1D', 'SLC25A4']",0.8380390639584117,0,0,10
17,Central carbon metabolism in cancer,0.06490457864615339,2.7683896202212224,7.571094664203814,"['LDHA', 'PKM', 'PGAM1', 'KRAS']",0.8380390639584117,0,0,4
18,Staphylococcus aureus infection,0.0668005046193598,3.3991336633663365,9.19820744496485,"['FCGR3A', 'KRT10', 'ICAM1']",0.8380390639584117,0,0,3
19,Vasopressin-regulated water reabsorption,0.07527839116327793,3.2198410630536736,8.328319039785955,"['CREB3', 'DCTN1', 'ARHGDIG']",0.8380390639584117,0,0,3
20,Proteasome,0.08420512724836687,3.058477722772277,7.568201491472351,"['PSMC3', 'PSME4', 'PSMB10']",0.8380390639584117,0,0,3
21,Parkinson disease,0.08672664816203983,1.7389660566985872,4.251761717155757,"['COX8A', 'NDUFB9', 'PINK1', 'PSMC3', 'NDUFS3', 'CYC1', 'COX5A', 'ATP5F1D', 'SLC25A4']",0.8380390639584117,0,0,9
22,Human papillomavirus infection,0.08740182436860101,1.6343599033816425,3.9833258971852614,"['CREB3', 'PKM', 'PARD6A', 'IRF3', 'LAMB3', 'LAMC3', 'BAD', 'HLA-B', 'KRAS', 'ATP6V0D1', 'TUBG1']",0.8380390639584117,0,0,11
23,Cardiac muscle contraction,0.08796266495161012,2.4737198285585382,6.013224075141662,"['COX8A', 'ATP1A3', 'CYC1', 'COX5A']",0.8380390639584117,0,0,4
24,Pathways of neurodegeneration,0.08886988075859574,1.5068484606556558,3.647450250018097,"['COX8A', 'NDUFB9', 'DCTN1', 'BAD', 'COX5A', 'ATP5F1D', 'HSD17B10', 'PINK1', 'PSMC3', 'ATG101', 'NDUFS3', 'KRAS', 'CYC1', 'SLC25A4', 'NEFH']",0.8380390639584117,0,0,15
25,Porphyrin and chlorophyll metabolism,0.09723824813951303,4.07283950617284,9.492123690286281,"['UROD', 'HCCS']",0.8380390639584117,0,0,2
26,Ras signaling pathway,0.1014620193101816,1.7412680637764624,3.9841445150881523,"['SHC3', 'RASA4B', 'BAD', 'VEGFB', 'RAC3', 'KRAS', 'FOXO4', 'ARF6']",0.8380390639584117,0,0,8
27,Chronic myeloid leukemia,0.10268379649411127,2.3317972350230414,5.307405900970752,"['SHC3', 'GADD45B', 'BAD', 'KRAS']",0.8380390639584117,0,0,4
28,Estrogen signaling pathway,0.10273493791831285,2.0835871662097674,4.741417260265645,"['POMC', 'CREB3', 'SHC3', 'KRAS', 'KRT10']",0.8380390639584117,0,0,5
29,Viral myocarditis,0.10332027006186502,2.779759225922592,6.3098357791316895,"['HLA-B', 'RAC3', 'ICAM1']",0.8380390639584117,0,0,3
30,Pancreatic cancer,0.10653038948623877,2.2988152238492994,5.147794371831438,"['GADD45B', 'BAD', 'RAC3', 'KRAS']",0.8380390639584117,0,0,4
31,Non-alcoholic fatty liver disease,0.11318563483671618,1.8713521539662294,4.077163634174513,"['COX8A', 'SOCS3', 'NDUFB9', 'NDUFS3', 'CYC1', 'COX5A']",0.8616712845633877,0,0,6
32,Colorectal cancer,0.135196590830007,2.0916205382706625,4.185385680851439,"['GADD45B', 'BAD', 'RAC3', 'KRAS']",0.866625634301001,0,0,4
33,Human immunodeficiency virus 1 infection,0.13555785760947917,1.6825735294117647,3.3623821469382547,"['CCNB1', 'IRF3', 'BAD', 'CFL2', 'HLA-B', 'RAC3', 'KRAS']",0.866625634301001,0,0,7
34,Fatty acid elongation,0.13683313296146757,3.257283950617284,6.4787153126442645,"['THEM5', 'ACOT4']",0.866625634301001,0,0,2
35,VEGF signaling pathway,0.14034776878506508,2.3972044263249854,4.707227019561486,"['BAD', 'RAC3', 'KRAS']",0.866625634301001,0,0,3
36,Prostate cancer,0.15283860965421478,1.9891060945348908,3.7362826911687623,"['CREB3', 'BAD', 'GSTP1', 'KRAS']",0.866625634301001,0,0,4
37,Hepatocellular carcinoma,0.15371471515534463,1.7010598503740648,3.185501455157881,"['SHC3', 'GADD45B', 'GSTO1', 'BAD', 'GSTP1', 'KRAS']",0.866625634301001,0,0,6
38,Endometrial cancer,0.15740497531758396,2.2636138613861387,4.185271123872446,"['GADD45B', 'BAD', 'KRAS']",0.866625634301001,0,0,3
39,cAMP signaling pathway,0.15904984006279188,1.6061657303370787,2.9529961936504296,"['POMC', 'CREB3', 'BAD', 'FSHR', 'FXYD1', 'RAC3', 'ATP1A3']",0.866625634301001,0,0,7
40,Aldosterone-regulated sodium reabsorption,0.1620125756986678,2.9077601410934744,5.292359912916909,"['ATP1A3', 'KRAS']",0.866625634301001,0,0,2
41,Prolactin signaling pathway,0.16911343402470064,2.1825053041018387,3.878716959025352,"['SOCS3', 'SHC3', 'KRAS']",0.866625634301001,0,0,3
42,Apoptosis,0.17101550100310797,1.7432070417145045,3.078505513880803,"['ENDOG', 'GADD45B', 'DIABLO', 'BAD', 'KRAS']",0.866625634301001,0,0,5
43,Glucagon signaling pathway,0.17129525615541086,1.896127878123377,3.3454646353578066,"['CREB3', 'LDHA', 'PKM', 'PGAM1']",0.866625634301001,0,0,4
44,Drug metabolism,0.17505996566432028,2.144085461177697,3.7363405777646004,"['GSTO1', 'GSTP1', 'IMPDH2']",0.866625634301001,0,0,3
45,Sulfur relay system,0.1770042497341067,5.808585503166784,10.058039412784682,['MOCS2'],0.866625634301001,0,0,1
46,Insulin signaling pathway,0.17905183604346298,1.7137004055353484,2.9477016705585095,"['SOCS3', 'SHC3', 'BAD', 'RPS6', 'KRAS']",0.866625634301001,0,0,5
47,Metabolism of xenobiotics by cytochrome P450,0.1792257098346822,2.71358024691358,4.664941089434871,"['GSTO1', 'GSTP1']",0.866625634301001,0,0,2
48,Phagosome,0.18722706744941223,1.685169195345586,2.8233883068089543,"['COLEC11', 'FCGR3A', 'HLA-B', 'ATP6V0D1', 'RILP']",0.866625634301001,0,0,5
49,"Glycine, serine and threonine metabolism",0.19669870766039005,2.543672839506173,4.13622093289651,"['GAMT', 'PGAM1']",0.866625634301001,0,0,2
50,Synthesis and degradation of ketone bodies,0.19680789165663656,5.082204433497537,8.261261518656779,['HMGCS1'],0.866625634301001,0,0,1
51,Melanoma,0.20560050323164733,1.9705764931331844,3.1170978951649775,"['GADD45B', 'BAD', 'KRAS']",0.866625634301001,0,0,3
52,Thyroid cancer,0.21436819541597613,2.393754538852578,3.6865261011943224,"['GADD45B', 'KRAS']",0.866625634301001,0,0,2
53,Type II diabetes mellitus,0.21436819541597613,2.393754538852578,3.6865261011943224,"['SOCS3', 'PKM']",0.866625634301001,0,0,2
54,Chemical carcinogenesis,0.22246331717887555,1.5010326943377752,2.256041718789725,"['CREB3', 'GSTO1', 'BAD', 'GSTP1', 'AIP', 'KRAS']",0.866625634301001,0,0,6
55,Cytosolic DNA-sensing pathway,0.22325830820871445,2.3252204585537917,3.486495651104582,"['IRF3', 'POLR3H']",0.866625634301001,0,0,2
56,Ovarian steroidogenesis,0.22325830820871445,2.3252204585537917,3.486495651104582,"['FSHR', 'ACOT4']",0.866625634301001,0,0,2
57,Synaptic vesicle cycle,0.23083449747530912,1.8506975697569756,2.7132231049484674,"['CLTC', 'SLC17A6', 'ATP6V0D1']",0.866625634301001,0,0,3
58,Pyruvate metabolism,0.23217620919802964,2.2604938271604937,3.300905716830021,"['LDHA', 'PKM']",0.866625634301001,0,0,2
59,Non-small cell lung cancer,0.23723174429230887,1.822964385990838,2.6227312955550603,"['GADD45B', 'BAD', 'KRAS']",0.866625634301001,0,0,3
60,Amoebiasis,0.24365927095090287,1.7960468841001747,2.535990290024723,"['LAMB3', 'LAMC3', 'PRDX1']",0.866625634301001,0,0,3
61,"Growth hormone synthesis, secretion and action",0.2462698471664121,1.6130506350883227,2.2604120598722632,"['SOCS3', 'CREB3', 'SHC3', 'KRAS']",0.866625634301001,0,0,4
62,Glioma,0.25011453731449385,1.7699095996556178,2.4528050006207347,"['SHC3', 'GADD45B', 'KRAS']",0.866625634301001,0,0,3
63,Insulin secretion,0.25659504468818045,1.7445190947666196,2.372992807234479,"['CREB3', 'ATP1A3', 'CCK']",0.866625634301001,0,0,3
64,Glutathione metabolism,0.2590334902440118,2.086229819563153,2.8180749002412466,"['GSTO1', 'GSTP1']",0.866625634301001,0,0,2
65,Ribosome biogenesis in eukaryotes,0.26309833698483803,1.7198438153674522,2.296382606300318,"['FBL', 'IMP3', 'RPP25']",0.866625634301001,0,0,3
66,Cellular senescence,0.26596518862844126,1.4653351945309425,1.9406750564074868,"['CCNB1', 'GADD45B', 'HLA-B', 'KRAS', 'SLC25A4']",0.866625634301001,0,0,5
67,Basal transcription factors,0.268000818249928,2.0339506172839505,2.678235483505279,"['GTF2A2', 'TAF10']",0.866625634301001,0,0,2
68,Neurotrophin signaling pathway,0.28345040982155795,1.5078577336641852,1.9009835255643124,"['SHC3', 'BAD', 'ARHGDIG', 'KRAS']",0.866625634301001,0,0,4
69,Relaxin signaling pathway,0.28345040982155795,1.5078577336641852,1.9009835255643124,"['CREB3', 'SHC3', 'VEGFB', 'KRAS']",0.866625634301001,0,0,4
70,Cysteine and methionine metabolism,0.28592532695388,1.9368606701940034,2.424997199696662,"['LDHA', 'AHCY']",0.866625634301001,0,0,2
71,Pentose and glucuronate interconversions,0.2889188981884611,3.1265630920803336,3.8819696850973338,['DCXR'],0.866625634301001,0,0,1
72,Arginine and proline metabolism,0.29487256382843685,1.8917025552684468,2.31016986659551,"['GAMT', 'CNDP2']",0.866625634301001,0,0,2
73,Focal adhesion,0.299276762125134,1.3427694500013703,1.6198989476781986,"['SHC3', 'LAMB3', 'LAMC3', 'BAD', 'VEGFB', 'RAC3']",0.866625634301001,0,0,6
74,FoxO signaling pathway,0.2996438200108954,1.4668365636107572,1.7677738917293433,"['CCNB1', 'GADD45B', 'KRAS', 'FOXO4']",0.866625634301001,0,0,4
75,Human T-cell leukemia virus 1 infection,0.30346788373423034,1.3353501492171211,1.5923776699019978,"['IL15RA', 'CREB3', 'HLA-B', 'KRAS', 'SLC25A4', 'ICAM1']",0.866625634301001,0,0,6
76,"Valine, leucine and isoleucine degradation",0.30380355909169443,1.8485970819304152,2.202370451164701,"['HMGCS1', 'HSD17B10']",0.866625634301001,0,0,2
77,ErbB signaling pathway,0.3090623322647803,1.5648324447829398,1.8374455039277893,"['SHC3', 'BAD', 'KRAS']",0.866625634301001,0,0,3
78,Fluid shear stress and atherosclerosis,0.31050012087174805,1.4406991809218472,1.6849999649136544,"['GSTO1', 'GSTP1', 'RAC3', 'ICAM1']",0.866625634301001,0,0,4
79,Endocrine and other factor-regulated calcium reabsorption,0.32159950063840076,1.7680085882984433,2.005714327514767,"['CLTC', 'ATP1A3']",0.866625634301001,0,0,2
80,Mineral absorption,0.33045632521526047,1.7302863146834777,1.9159127732795003,"['ATP1A3', 'FTL']",0.866625634301001,0,0,2
81,Influenza A,0.33231425350011223,1.3911051727428898,1.5325446936988572,"['SOCS3', 'IRF3', 'SLC25A4', 'ICAM1']",0.866625634301001,0,0,4
82,Hepatitis C,0.3377820069812377,1.3792320309542836,1.4969557483417328,"['SOCS3', 'IRF3', 'BAD', 'KRAS']",0.866625634301001,0,0,4
83,Histidine metabolism,0.3390458077003806,2.5398706896551726,2.747175074454948,['CNDP2'],0.866625634301001,0,0,1
84,AGE-RAGE signaling pathway in diabetic complications,0.34867863128079973,1.45252828854314,1.530390498462097,"['VEGFB', 'KRAS', 'ICAM1']",0.866625634301001,0,0,3
85,Aldosterone synthesis and secretion,0.34867863128079973,1.45252828854314,1.530390498462097,"['POMC', 'CREB3', 'ATP1A3']",0.866625634301001,0,0,3
86,Allograft rejection,0.3549587277521585,2.390321645899739,2.475784623072002,['HLA-B'],0.866625634301001,0,0,1
87,Graft-versus-host disease,0.3549587277521585,2.390321645899739,2.475784623072002,['HLA-B'],0.866625634301001,0,0,1
88,Small cell lung cancer,0.35526833075902786,1.4353523587652883,1.4854201959201483,"['GADD45B', 'LAMB3', 'LAMC3']",0.866625634301001,0,0,3
89,Melanogenesis,0.3618494547063629,1.4185758692148285,1.4420207075471083,"['POMC', 'CREB3', 'KRAS']",0.866625634301001,0,0,3
90,Epstein-Barr virus infection,0.36486809546304705,1.271377487562189,1.2818274133651453,"['GADD45B', 'PSMC3', 'IRF3', 'HLA-B', 'ICAM1']",0.866625634301001,0,0,5
91,PI3K-Akt signaling pathway,0.36820575817827655,1.188445566470922,1.1873918568574588,"['CREB3', 'LAMB3', 'LAMC3', 'BAD', 'RPS6', 'VEGFB', 'KRAS', 'EPOR']",0.866625634301001,0,0,8
92,TNF signaling pathway,0.3684202877447002,1.402185046090816,1.4001251047819618,"['SOCS3', 'CREB3', 'ICAM1']",0.866625634301001,0,0,3
93,Pathogenic Escherichia coli infection,0.3696474551775365,1.2634034794969253,1.257346156470543,"['MYO1D', 'MYO1E', 'CYTH4', 'GAPDH', 'ARF6']",0.866625634301001,0,0,5
94,Phototransduction,0.370489451379396,2.2573891625615765,2.241430111857531,['PDE6G'],0.866625634301001,0,0,1
95,Phospholipase D signaling pathway,0.3706205286844221,1.3120147282478187,1.3022750834255292,"['SHC3', 'CYTH4', 'KRAS', 'ARF6']",0.866625634301001,0,0,4
96,Fc gamma R-mediated phagocytosis,0.37497916105273416,1.3861667416741674,1.3596699219413677,"['FCGR3A', 'CFL2', 'ARF6']",0.866625634301001,0,0,3
97,Choline metabolism in cancer,0.38152445214003616,1.3705083991545222,1.3205949431727786,"['CHKA', 'RAC3', 'KRAS']",0.866625634301001,0,0,3
98,Cortisol synthesis and secretion,0.3827967891701773,1.5338457954810156,1.4728769699789994,"['POMC', 'CREB3']",0.866625634301001,0,0,2
99,Proximal tubule bicarbonate reclamation,0.38564713614784557,2.138449572206378,2.037584214948414,['ATP1A3'],0.866625634301001,0,0,1
100,Neutrophil extracellular trap formation,0.39456802738320346,1.3402241323033401,1.2463598117510495,"['FCGR3A', 'CLCN4', 'SLC25A4']",0.866625634301001,0,0,3
101,Folate biosynthesis,0.40044072070993325,2.0314039408866993,1.8591196313835174,['MOCS2'],0.866625634301001,0,0,1
102,Terpenoid backbone biosynthesis,0.40044072070993325,2.0314039408866993,1.8591196313835174,['HMGCS1'],0.866625634301001,0,0,1
103,Longevity regulating pathway,0.4010632952964643,1.325575764098149,1.211093765981194,"['CREB3', 'ATG101', 'KRAS']",0.866625634301001,0,0,3
104,Chemokine signaling pathway,0.40334815463623536,1.2510020996373354,1.135853839937587,"['SHC3', 'BAD', 'RAC3', 'KRAS']",0.866625634301001,0,0,4
105,Alcoholism,0.40753894763916093,1.3112424145640371,1.176995808367706,"['CREB3', 'SHC3', 'KRAS']",0.866625634301001,0,0,3
106,Toxoplasmosis,0.40753894763916093,1.3112424145640371,1.176995808367706,"['LAMB3', 'LAMC3', 'BAD']",0.866625634301001,0,0,3
107,Fc epsilon RI signaling pathway,0.40831653903000265,1.451410934744268,1.300047024905992,"['RAC3', 'KRAS']",0.866625634301001,0,0,2
108,Hepatitis B,0.41419556727591517,1.2318971351229415,1.0858151165335537,"['CREB3', 'IRF3', 'BAD', 'KRAS']",0.866625634301001,0,0,4
109,Autoimmune thyroid disease,0.41487892989024816,1.9345531315974667,1.7019589774030806,['HLA-B'],0.866625634301001,0,0,1
110,Pertussis,0.41670962789246463,1.4258609486679663,1.2481496757892376,"['IRF3', 'CFL2']",0.866625634301001,0,0,2
111,Acute myeloid leukemia,0.4250423721651805,1.4011919965942954,1.198812814395079,"['BAD', 'KRAS']",0.866625634301001,0,0,2
112,Adipocytokine signaling pathway,0.4250423721651805,1.4011919965942954,1.198812814395079,"['POMC', 'SOCS3']",0.866625634301001,0,0,2
113,HIF-1 signaling pathway,0.4268344692890217,1.2700340346534653,1.081254906543785,"['LDHA', 'RPS6', 'GAPDH']",0.866625634301001,0,0,3
114,Collecting duct acid secretion,0.42897028019923483,1.8465069413345276,1.5628237210337572,['ATP6V0D1'],0.866625634301001,0,0,1
115,Protein export,0.42897028019923483,1.8465069413345276,1.5628237210337572,['SRP9'],0.866625634301001,0,0,1
116,Type I diabetes mellitus,0.42897028019923483,1.8465069413345276,1.5628237210337572,['HLA-B'],0.866625634301001,0,0,1
117,PPAR signaling pathway,0.4333128171505005,1.377359280184139,1.1518791893386378,"['HMGCS1', 'DBI']",0.866625634301001,0,0,2
118,Thyroid hormone synthesis,0.4333128171505005,1.377359280184139,1.1518791893386378,"['CREB3', 'ATP1A3']",0.866625634301001,0,0,2
119,Rheumatoid arthritis,0.4415191364546507,1.354320987654321,1.1072033401507937,"['ATP6V0D1', 'ICAM1']",0.8680706303972895,0,0,2
120,Butanoate metabolism,0.442723084354171,1.7661169415292355,1.439051151203092,['HMGCS1'],0.8680706303972895,0,0,1
121,GnRH secretion,0.4496596269727747,1.3320380489779398,1.0646505479374377,"['GNRH1', 'KRAS']",0.8680706303972895,0,0,2
122,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,0.456145456367877,1.6924261083743843,1.328458935735663,['PIGP'],0.8680706303972895,0,0,1
123,Intestinal immune network for IgA production,0.456145456367877,1.6924261083743843,1.328458935735663,['IL15RA'],0.8680706303972895,0,0,1
124,B cell receptor signaling pathway,0.4577327043946622,1.31047391477499,1.0240958930484223,"['RAC3', 'KRAS']",0.8680706303972895,0,0,2
125,Human cytomegalovirus infection,0.4597831728799203,1.1287313432835822,0.8770245516375443,"['CREB3', 'IRF3', 'HLA-B', 'RAC3', 'KRAS']",0.8680706303972895,0,0,5
126,cGMP-PKG signaling pathway,0.4676508776846129,1.144444832768322,0.8698161248995433,"['CREB3', 'BAD', 'ATP1A3', 'SLC25A4']",0.8683906350835384,0,0,4
127,JAK-STAT signaling pathway,0.4709308464862,1.1832163798904163,0.8910140174584198,"['IL15RA', 'SOCS3', 'EPOR']",0.8683906350835384,0,0,3
128,Mitophagy,0.4736708465234206,1.2693672839506174,0.9485253288111097,"['PINK1', 'KRAS']",0.8683906350835384,0,0,2
129,p53 signaling pathway,0.4815332936013659,1.2497625830959165,0.913301381178569,"['CCNB1', 'GADD45B']",0.8683906350835384,0,0,2
130,Biosynthesis of unsaturated fatty acids,0.4820303948980659,1.5620500189465707,1.139903044311275,['ACOT4'],0.8683906350835384,0,0,1
131,beta-Alanine metabolism,0.4820303948980659,1.5620500189465707,1.139903044311275,['CNDP2'],0.8683906350835384,0,0,1
132,Renal cell carcinoma,0.4893230834624364,1.2307519640852975,0.8796581885405037,"['BAD', 'KRAS']",0.8748503613419317,0,0,2
133,Citrate cycle (TCA cycle),0.4945082378596648,1.5041050903119868,1.0591779732127737,['ACLY'],0.8774732641720367,0,0,1
134,RNA polymerase,0.5066862105767875,1.4502990851513018,0.9860052395604014,['POLR3H'],0.8808247541518524,0,0,1
135,Pathways in cancer,0.5183879722093115,1.0195966514459665,0.6699069500500474,"['IL15RA', 'LAMB3', 'GADD45B', 'LAMC3', 'GSTO1', 'BAD', 'GSTP1', 'VEGFB', 'RAC3', 'KRAS', 'EPOR']",0.8808247541518524,0,0,11
136,Kaposi sarcoma-associated herpesvirus infection,0.5192505800901062,1.0684994123024683,0.7002610697842022,"['IRF3', 'HLA-B', 'KRAS', 'ICAM1']",0.8808247541518524,0,0,4
137,Pancreatic secretion,0.5197358553476681,1.1601410934744267,0.75923643411189,"['ATP1A3', 'CCK']",0.8808247541518524,0,0,2
138,Thyroid hormone signaling pathway,0.5252450999704983,1.0875397807637908,0.7002562811660568,"['BAD', 'ATP1A3', 'KRAS']",0.8808247541518524,0,0,3
139,Purine metabolism,0.5310905403182804,1.0778498203802682,0.6820879016490056,"['PKM', 'PDE6G', 'IMPDH2']",0.8808247541518524,0,0,3
140,Base excision repair,0.5414919437762086,1.3097092006991895,0.8034111040690707,['TDG'],0.8808247541518524,0,0,1
141,Nicotinate and nicotinamide metabolism,0.5414919437762086,1.3097092006991895,0.8034111040690707,['ASPDH'],0.8808247541518524,0,0,1
142,SNARE interactions in vesicular transport,0.5414919437762086,1.3097092006991895,0.8034111040690707,['USE1'],0.8808247541518524,0,0,1
143,Propanoate metabolism,0.5525406286190909,1.2687038177339902,0.7526310246431325,['LDHA'],0.8808247541518524,0,0,1
144,Bacterial invasion of epithelial cells,0.5560157250437568,1.0824691358024692,0.6353646796403462,"['SHC3', 'CLTC']",0.8808247541518524,0,0,2
145,ECM-receptor interaction,0.563034772242804,1.06816114359974,0.6135665979934596,"['LAMB3', 'LAMC3']",0.8808247541518524,0,0,2
146,NF-kappa B signaling pathway,0.563034772242804,1.06816114359974,0.6135665979934596,"['GADD45B', 'ICAM1']",0.8808247541518524,0,0,2
147,Peroxisome,0.563034772242804,1.06816114359974,0.6135665979934596,"['PEX19', 'PRDX1']",0.8808247541518524,0,0,2
148,Carbohydrate digestion and absorption,0.5633237103673725,1.2301836094939542,0.7060034093857568,['ATP1A3'],0.8808247541518524,0,0,1
149,Systemic lupus erythematosus,0.5633237103673725,1.2301836094939542,0.7060034093857568,['FCGR3A'],0.8808247541518524,0,0,1
150,Apelin signaling pathway,0.5652944226013664,1.0231300440968467,0.5836021572587713,"['RPS6', 'APLNR', 'KRAS']",0.8808247541518524,0,0,3
151,Lipid and atherosclerosis,0.5683859471278548,1.001929969671905,0.566044951882743,"['IRF3', 'BAD', 'KRAS', 'ICAM1']",0.8808247541518524,0,0,4
152,Bladder cancer,0.5738475586930513,1.1939292958562735,0.6630981766982513,['KRAS'],0.8808247541518524,0,0,1
153,Yersinia infection,0.5763525289894632,1.0060960641518697,0.5543949254448164,"['IRF3', 'RAC3', 'ARF6']",0.8808247541518524,0,0,3
154,Breast cancer,0.592606306459573,0.9815753752794635,0.5135847775777197,"['SHC3', 'GADD45B', 'KRAS']",0.8808247541518524,0,0,3
155,Nicotine addiction,0.5941422746613109,1.1274630541871922,0.5869983830855484,['SLC17A6'],0.8808247541518524,0,0,1
156,GnRH signaling pathway,0.5969292031896343,1.001920438957476,0.5169476237064011,"['GNRH1', 'KRAS']",0.8808247541518524,0,0,2
157,Axon guidance,0.6010730335750665,0.9600187939565683,0.4886868453224373,"['PARD6A', 'CFL2', 'RAC3', 'KRAS']",0.8808247541518524,0,0,4
158,Gastric cancer,0.6032159848780358,0.9658769448373409,0.48823144186579065,"['SHC3', 'GADD45B', 'KRAS']",0.8808247541518524,0,0,3
159,Various types of N-glycan biosynthesis,0.6039251341053958,1.0969245107176142,0.5531845580328993,['CHST8'],0.8808247541518524,0,0,1
160,Ferroptosis,0.613472750355179,1.0679932590095929,0.5218422601488176,['FTL'],0.8808247541518524,0,0,1
161,Autophagy,0.6136421156875361,0.9506690903465347,0.4642529703834843,"['ATG101', 'BAD', 'KRAS']",0.8808247541518524,0,0,3
162,Glycerophospholipid metabolism,0.616301780410964,0.9659611992945326,0.46754312179396973,"['PHOSPHO1', 'CHKA']",0.8808247541518524,0,0,2
163,Cholesterol metabolism,0.6227907666967599,1.0405456612353163,0.49274484615381975,['APOC1'],0.8808247541518524,0,0,1
164,MAPK signaling pathway,0.6237109204199768,0.9318084100094591,0.43987719947107506,"['MAP4K1', 'DUSP3', 'GADD45B', 'VEGFB', 'RAC3', 'KRAS']",0.8808247541518524,0,0,6
165,Tuberculosis,0.623882888653907,0.9359291698400609,0.4415644626933662,"['FCGR3A', 'BAD', 'ATP6V0D1']",0.8808247541518524,0,0,3
166,Adrenergic signaling in cardiomyocytes,0.6289332985784085,0.928727987302547,0.43067909595609444,"['CREB3', 'ATP1A3', 'SCN1B']",0.8808247541518524,0,0,3
167,Retrograde endocannabinoid signaling,0.6289332985784085,0.928727987302547,0.43067909595609444,"['NDUFB9', 'NDUFS3', 'SLC17A6']",0.8808247541518524,0,0,3
168,Ubiquitin mediated proteolysis,0.6289332985784085,0.928727987302547,0.43067909595609444,"['SOCS3', 'FBXO2', 'STUB1']",0.8808247541518524,0,0,3
169,Cushing syndrome,0.6339368511015537,0.9216359135913591,0.42008711789230885,"['POMC', 'CREB3', 'AIP']",0.8808247541518524,0,0,3
170,Progesterone-mediated oocyte maturation,0.6349529249898218,0.9324819071945508,0.42353740075160146,"['CCNB1', 'KRAS']",0.8808247541518524,0,0,2
171,mRNA surveillance pathway,0.6469887066232466,0.9114162851990567,0.3968547480766689,"['SSU72', 'PELO']",0.8808247541518524,0,0,2
172,Salmonella infection,0.6481405428827163,0.9045731165600569,0.3922660686485244,"['CYTH4', 'DCTN1', 'GAPDH', 'RILP', 'ARF6']",0.8808247541518524,0,0,5
173,Spinocerebellar ataxia,0.6486651758617722,0.900990099009901,0.38998329592302106,"['PSMC3', 'ATG101', 'SLC25A4']",0.8808247541518524,0,0,3
174,Cocaine addiction,0.6494216407729759,0.9660450387051372,0.41701565235739146,['CREB3'],0.8808247541518524,0,0,1
175,Rap1 signaling pathway,0.6658681858110633,0.8809472434998382,0.35824913096672967,"['PARD6A', 'VEGFB', 'RAC3', 'KRAS']",0.8890138903847131,0,0,4
176,Legionellosis,0.6661250840512609,0.9220219435736677,0.37459705802239646,['EEF1G'],0.8890138903847131,0,0,1
177,Endocytosis,0.6667604177885349,0.884551043907102,0.3585302019114694,"['CYTH4', 'PARD6A', 'CLTC', 'HLA-B', 'ARF6']",0.8890138903847131,0,0,5
178,RIG-I-like receptor signaling pathway,0.6741766656193459,0.9014778325123153,0.3554194333371454,['IRF3'],0.8938522083492451,0,0,1
179,Vibrio cholerae infection,0.6820345432977364,0.8818269436710217,0.337453101352632,['ATP6V0D1'],0.8992187274763451,0,0,1
180,Insulin resistance,0.68664420254236,0.8445987654320988,0.3175176331375744,"['SOCS3', 'CREB3']",0.9002668433333165,0,0,2
181,Measles,0.697282378240508,0.8272612748803225,0.29828130976824335,"['IRF3', 'BAD']",0.901017947765071,0,0,2
182,Cholinergic synapse,0.7024885694439538,0.8188552188552188,0.2891591901545453,"['CREB3', 'KRAS']",0.901017947765071,0,0,2
183,Necroptosis,0.7024885694439538,0.8188552188552188,0.2891591901545453,"['SLC25A4', 'FTL']",0.901017947765071,0,0,2
184,Osteoclast differentiation,0.7024885694439538,0.8188552188552188,0.2891591901545453,"['SOCS3', 'FCGR3A']",0.901017947765071,0,0,2
185,Antigen processing and presentation,0.711620339441127,0.8110837438423645,0.2759394014330306,['HLA-B'],0.9077967573411134,0,0,1
186,Basal cell carcinoma,0.7319927908025231,0.7650339250859746,0.23867881358515622,['GADD45B'],0.914283330801166,0,0,1
187,Notch signaling pathway,0.7319927908025231,0.7650339250859746,0.23867881358515622,['DTX3'],0.914283330801166,0,0,1
188,Taste transduction,0.7384593751469045,0.7508210180623974,0.22764081516051915,['TAS2R13'],0.914283330801166,0,0,1
189,Hematopoietic cell lineage,0.7447703041035112,0.7371249440214958,0.21721555449635466,['EPOR'],0.914283330801166,0,0,1
190,Bile secretion,0.7509293155619661,0.7239180154820549,0.20736179254653572,['ATP1A3'],0.914283330801166,0,0,1
191,Leishmaniasis,0.7509293155619661,0.7239180154820549,0.20736179254653572,['FCGR3A'],0.914283330801166,0,0,1
192,Protein processing in endoplasmic reticulum,0.7512619213506634,0.7638707266953111,0.21846773408851164,"['SELENOS', 'FBXO2', 'STUB1']",0.914283330801166,0,0,3
193,Sphingolipid signaling pathway,0.754968120375951,0.7364758698092031,0.20700845726459077,"['RAC3', 'KRAS']",0.914283330801166,0,0,2
194,Long-term depression,0.7569400576504817,0.711174487943998,0.19804162214257565,['KRAS'],0.914283330801166,0,0,1
195,Shigellosis,0.7570435727805436,0.7743835112256164,0.21553762214902825,"['CYTH4', 'IRF3', 'FOXO4', 'ARF6']",0.914283330801166,0,0,4
196,Cell adhesion molecules,0.7593200543941887,0.7297964631297965,0.20093625514429553,"['HLA-B', 'ICAM1']",0.914283330801166,0,0,2
197,Amphetamine addiction,0.7741178507643428,0.6754926108374384,0.17294715335589664,['CREB3'],0.9198929307033666,0,0,1
198,IL-17 signaling pathway,0.7741178507643428,0.6754926108374384,0.17294715335589664,['MAPK4'],0.9198929307033666,0,0,1
199,Cell cycle,0.7760653831069927,0.7042404723564144,0.17853799225253497,"['CCNB1', 'GADD45B']",0.9198929307033666,0,0,2
200,Epithelial cell signaling in Helicobacter pylori infection,0.7795702802570904,0.6643785835419527,0.1654385280919203,['ATP6V0D1'],0.9198929307033666,0,0,1
201,Lysosome,0.7879485246592858,0.6862105042896003,0.1635394134037397,"['CLTC', 'ATP6V0D1']",0.9230689006329594,0,0,2
202,Long-term potentiation,0.7900843979993976,0.6432090077410274,0.15155001602634446,['KRAS'],0.9230689006329594,0,0,1
203,Gastric acid secretion,0.800098179276393,0.623342175066313,0.139018292217362,['ATP1A3'],0.9301634005380727,0,0,1
204,Adherens junction,0.8096353777452049,0.6046614219542681,0.12768712861497164,['RAC3'],0.932068044623748,0,0,1
205,Salivary secretion,0.8096353777452049,0.6046614219542681,0.12768712861497164,['ATP1A3'],0.932068044623748,0,0,1
206,Toll-like receptor signaling pathway,0.8187186219274538,0.5870636110516171,0.11742142080845297,['IRF3'],0.9379494891984422,0,0,1
207,Spliceosome,0.8300960489695204,0.622412155745489,0.11590177204685168,"['BUD31', 'SRSF3']",0.9463896983420619,0,0,2
208,Protein digestion and absorption,0.8434551383625816,0.5399014778325123,0.09191745104174116,['ATP1A3'],0.9512693864545996,0,0,1
209,Cytokine-cytokine receptor interaction,0.8510525073257913,0.590357754348022,0.09521375557087779,"['IL15RA', 'EPOR']",0.9512693864545996,0,0,2
210,Oxytocin signaling pathway,0.8538467702629654,0.5860440150295223,0.09259702147726606,"['MYL6', 'KRAS']",0.9512693864545996,0,0,2
211,Regulation of actin cytoskeleton,0.8539407642093232,0.6279946647514493,0.09915624442014276,"['CFL2', 'RAC3', 'KRAS']",0.9512693864545996,0,0,3
212,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.8545301268151488,0.5190413035240622,0.0815951201412541,['KRAS'],0.9512693864545996,0,0,1
213,Tight junction,0.8645523972626281,0.569396626673622,0.08287190151599552,"['MYL6', 'PARD6A']",0.9528805928330603,0,0,2
214,mTOR signaling pathway,0.8645523972626281,0.569396626673622,0.08287190151599552,"['RPS6', 'KRAS']",0.9528805928330603,0,0,2
215,Gap junction,0.8680903705894405,0.4936020665625375,0.06982467989485806,['KRAS'],0.9528805928330603,0,0,1
216,C-type lectin receptor signaling pathway,0.8743899427181466,0.48179099225897254,0.06467024799323937,['KRAS'],0.9553519744513084,0,0,1
217,T cell receptor signaling pathway,0.8803893667277611,0.47052927024859664,0.05994119764312303,['KRAS'],0.9574741499896388,0,0,1
218,"Parathyroid hormone synthesis, secretion and action",0.894166750139888,0.44454068099388294,0.04972765410569097,['CREB3'],0.9628596756801079,0,0,1
219,Phosphatidylinositol signaling system,0.894166750139888,0.44454068099388294,0.04972765410569097,['PIP4P1'],0.9628596756801079,0,0,1
220,RNA transport,0.9005589131156834,0.5112361306454134,0.05354671580098543,"['EIF3G', 'RPP25']",0.9628596756801079,0,0,2
221,Leukocyte transendothelial migration,0.901660967480101,0.4302746043391678,0.044540605893272335,['ICAM1'],0.9628596756801079,0,0,1
222,Serotonergic synapse,0.9129932542304904,0.4084191670398567,0.037177084520790604,['KRAS'],0.9705694053981789,0,0,1
223,Glutamatergic synapse,0.9248853879432386,0.38494018296973964,0.03005822897805495,['SLC17A6'],0.9722321459705017,0,0,1
224,Vascular smooth muscle contraction,0.9267033489361222,0.3812854354493912,0.029024124725213783,['MYL6'],0.9722321459705017,0,0,1
225,Proteoglycans in cancer,0.9343801669126877,0.45067935719704805,0.03058846093419274,"['RPS6', 'KRAS']",0.9722321459705017,0,0,2
226,AMPK signaling pathway,0.9351554963360333,0.3639994674477433,0.02440341874596343,['CREB3'],0.9722321459705017,0,0,1
227,Oocyte meiosis,0.9351554963360333,0.3639994674477433,0.02440341874596343,['CCNB1'],0.9722321459705017,0,0,1
228,Signaling pathways regulating pluripotency of stem cells,0.9397525018588604,0.3543557168784029,0.022019215732190203,['KRAS'],0.9727262738539082,0,0,1
229,Dopaminergic synapse,0.9504830891868414,0.3309577646773803,0.016807659863999787,['CREB3'],0.9750948745271676,0,0,1
230,NOD-like receptor signaling pathway,0.9572596548462116,0.3153286637931034,0.013773746067891947,['IRF3'],0.9750948745271676,0,0,1
231,Calcium signaling pathway,0.9579835609337102,0.400810761009766,0.01720466601561493,"['VEGFB', 'SLC25A4']",0.9750948745271676,0,0,2
232,Herpes simplex virus 1 infection,0.9595785263786251,0.5466447517569712,0.02255517795029973,"['SOCS3', 'IRF3', 'BAD', 'HLA-B', 'SRSF3', 'ZNF534']",0.9750948745271676,0,0,6
233,Transcriptional misregulation in cancer,0.9640050640072072,0.2988505747126437,0.010955482907044442,['GADD45B'],0.9750948745271676,0,0,1
234,Wnt signaling pathway,0.9711406496629326,0.2800184729064039,0.008200052800384773,['RAC3'],0.9750948745271676,0,0,1
235,Hippo signaling pathway,0.9725238158895441,0.2761488629462177,0.007693704614254001,['PARD6A'],0.9750948745271676,0,0,1
236,MicroRNAs in cancer,0.9750948745271676,0.2687192118226601,0.006777234362678984,['KRAS'],0.9750948745271676,0,0,1
